Chronotherapy: maximizing drug efficacy, reducing side effects, and improving patient outcomes through circadian alignment

Abstract

Our aim in this review is to provide an inclusive overview of the scientific principles, clinical applications, challenges, and prospects of chronotherapy. Circadian rhythms are internal timing systems that govern almost all physiological functions in the human body. Circadian rhythms influence health and illness in a variety of ways, including hormone secretion, blood pressure regulation, drug metabolism, and sleep-wake cycles. The practice of coordinating medical care with these innate biological cycles, or chronotherapy, has become a cutting-edge strategy to increase medication effectiveness, minimize adverse effects, and enhance patient outcomes. This review article examines the science underlying chronotherapy and its use across a variety of therapeutic domains, including cancer, cardiovascular disease, diabetes, asthma, neurological disorders, and psychiatric conditions. The evidence suggests that, by moving away from “one-size-fits-all” dosing and toward customized, rhythm-based care, chronotherapy has the potential to completely transform contemporary medicine.

Keywords

Review

IntroductionModern medicine has long been guided by fixed dosing schedules: “Take one tablet in the morning and one at night.” While convenient, this approach often overlooks the body’s biological rhythms.⁵ The physiology of human organs changes throughout the day; those oscillations are controlled by internal clocks called circadian rhythms.⁶ The suprachiasmatic nucleus (SCN) is the primary circadian pacemaker in mammals that affects different physiological functions, including those relevant to drug administration and response.^7,8 In response to these variations, chronotherapy emerged as a paradigm shift, and it is a therapeutic strategy that optimizes drug administration to be aligned with the body’s circadian rhythms, thereby enhancing drug efficacy, reducing adverse drug reactions, and improving patient adherence.⁹
Circadian rhythms coordinate diverse processes such as body temperature, hormone secretion, digestion, cardiovascular activity, and immune responses.¹⁰ Disruption of these rhythms due to factors such as shift work, artificial light at night, irregular sleep–wake cycles, or mistimed eating has been increasingly recognized as an independent risk factor for different diseases, with a growing body of evidence linking circadian misalignment to key pathophysiological mechanisms, including endothelial dysfunction, oxidative stress, inflammation, and autonomic imbalance.¹¹ Consequently, linking the disruption of circadian rhythms to the onset and progression of numerous diseases emphasizes the crucial role of these biological rhythms in health promotion and improving treatment outcomes.¹² Therefore, the interrelationship between physiological functions and circadian regulation provides the fundamental basis for chronotherapy, aiming to leverage these dynamics to optimize pharmacotherapy.¹³ This field acknowledges that a drug’s efficacy and toxicity depend not merely upon the time of administration, because the pharmacokinetic parameters, such as absorption, distribution, metabolism, and excretion, are significantly affected by circadian fluctuations.^12,14 For example, the same drug has different effects when taken in the morning or evening, an observation which led to the rise of chronotherapy.³
Chronotherapy is the art of using existing drugs more sensibly, rather than inventing and prescribing new ones. Studies have found that some antihypertensive medications may lower morning surrogates more effectively when taken at night; adverse drug reactions associated with cancer chemotherapy may be reduced when used at specific times of day; and using anti-asthmatic medications in the evening can control symptoms that often worsen at night.^3,9,15
Our aim in this review is to provide an inclusive overview of the scientific principles, clinical applications, challenges, and prospects of chronotherapy.Biological Basis of ChronotherapyThe Circadian SystemThe circadian system of mammals is composed of a hierarchy of oscillators that function at the cellular, tissue, and systems levels.¹⁶ A master pacemaker located in the suprachiasmatic nucleus (SCN) synchronizes peripheral tissue clocks and extra-SCN oscillators in the brain with each other and with external time. Different time cues (so-called Zeitgebers) such as light, food intake, activity, and hormonal signals reset the clock system through the SCN or by direct action at the tissue clock level.¹⁷ Peripheral clocks exist in nearly every organ, including the liver, heart, lungs, and kidneys.¹⁸ These peripheral clocks, while influenced by the central pacemaker, also possess autonomous oscillatory capabilities, allowing for tissue-specific regulation of physiological processes.¹⁹ At the molecular level, circadian clocks are based on a system of transcriptional/translational feedback loops oscillating with a period of about 24 h.²⁰ In mammals, the CLOCK/BMAL1 transcriptional activator complex regulates a set of central clock genes like mPer1, mPer2, mCry1, and mCry2.²¹ These genes regulate cycles of transcription and translation, generating 24-hour oscillations. This molecular machinery influences gene expression related to metabolism, hormone release, enzyme activity, and cell division.²⁰Relevance to Drug ActionPharmacokinetics is the study of how the body affects drugs through the stages of absorption, distribution, metabolism, and excretion (ADME). Each of these is affected by circadian rhythms.²²AbsorptionGastrointestinal motility, enzyme activity, and pH fluctuate throughout the day and are among the main factors affecting drug absorption. A drug is considered bioavailable when it reaches the systemic circulation. Drug bioavailability is affected by several factors, including the time of administration. These effects on drug bioavailability emphasize the need to consider chronotherapy.^3,23,24DistributionPlasma protein binding and blood flow are among the many factors that affect the distribution of a drug among different body tissues, and they vary with circadian variation.⁴ This circadian modulation of distribution can alter drug concentrations at target sites, thereby leading to pharmacodynamic drug alterations.MetabolismActivity of liver enzymes, particularly that of cytochrome P450 isoforms, is the cornerstone of a drug’s biotransformation, exhibiting significant diurnal oscillations.²⁵ Such rhythmic fluctuations in P450 activity constitute a cornerstone of hepatic drug metabolism, profoundly shaping therapeutic efficacy and toxicity.²³ Indeed, the timing of drug administration can markedly alter hepatic metabolism because circadian-driven fluctuations in P450 expression and activity affect absorption, distribution, metabolism, and excretion processes.²⁶EliminationCircadian rhythm is clearly noticed in renal function, where the blood flow to the kidneys, glomerular filtration rate, and rates of tubular secretion affect the elimination of drugs and their metabolites.^19,27 The circadian variability in the pharmacokinetic parameters in the light of drug elimination emphasizes the rational need for chronotherapy, showing that the drug dosing and dosing intervals are not static variables, yet they depend crucially on the body’s biological clock; thereby, treatment outcomes can be optimized through enhancing efficacy and reducing adverse drug reactions.^28-30 Furthermore, the circadian clock also influences cellular processes essential for the action of drugs, such as cell cycle regulation, DNA repair mechanisms, and immune responses, thereby modulating the pharmacodynamic effects of various therapeutic agents; therefore, the complex interaction between pharmacokinetics, pharmacodynamics, and the circadian system offers a fundamental understanding for optimizing drug administration timings in diverse therapeutic contexts.^31,32 Therefore, a detailed understanding of the chronobiological regulation of drug disposition and cellular responsiveness is essential for developing effective chronotherapeutic strategies.^6,33,34Chronotherapy in Different DiseasesCardiovascular DiseasesA strong circadian rhythm is strongly associated with cardiovascular events. The incidence of various cardiovascular diseases, including acute myocardial infarction and arrhythmia, exhibits diurnal variation, underscoring the importance of understanding how the body’s internal clock influences cardiovascular function.³⁵ For example, the occurrence of ischemic heart disease, including myocardial ischemia, angina pectoris, acute myocardial infarction, and sudden cardiac death, is disproportionately higher during the initial hours of daily activity and in the late afternoon or early evening.³⁶ Early morning is associated with high rates of strokes and heart attacks, which is the time of peaks of blood pressure, platelet aggregation, and sympathetic activity.³ Consequently, by targeting those high-risk periods, the treatment outcome of antihypertensive, antiplatelet, and lipid-lowering drugs can be improved significantly.³ For instance, administering certain antihypertensives at night can more effectively control the nocturnal blood pressure dip and subsequent morning surge, which are critical in preventing adverse cardiovascular events.³⁷ Therefore, the approach of aligning the drug effects with natural circadian rhythms of cardiovascular risk can protect effectively against myocardial infarction and stroke.³⁷ Similarly, because cholesterol synthesis peaks nocturnally, HMG-CoA reductase inhibitors (statins) are prescribed for evening administration to maximize their therapeutic benefit. Moreover, chronotherapy in cardiovascular diseases extends to conditions like congestive heart failure and arrhythmia, where symptom exacerbation and physiological vulnerabilities often exhibit predictable daily patterns, thus benefiting from timed interventions.³⁸CancerOne of the most-studied areas of chronotherapy is oncology. While DNA repair and cell division follow circadian rhythms, the timing of oncology medication administration can maximize tumor killing and spare healthy cells by exploiting the differential circadian sensitivities between rapidly dividing cancer cells and normal quiescent cells, thereby improving the therapeutic index of cytotoxic agents.^39,40 For example, gastrointestinal adverse drug reactions and bone marrow toxicity due to oxaliplatin and 5-fluorouracil show reduction when administered according to circadian schedules.⁴¹ This strategic timing enhances treatment tolerability and can improve patient outcomes by reducing severe side effects associated with conventional chemotherapy regimens.⁴² Clinical trials have shown a significant association between tolerability and improved survival rates when chemotherapy is administered according to the circadian cycle.⁴³Asthma and Respiratory DisordersAsthma symptoms and signs, including coughing, wheezing, and airway narrowing, worsen at night and in the early morning. This pattern is directly associated with circadian declines in lung function and cortisol levels. To address nocturnal airway inflammation and bronchoconstriction, corticosteroids and bronchodilators may be administered in the evening. Studies have found that inhaled corticosteroids and bronchodilators are more effective when administered in the late afternoon or evening. Time-targeted treatment may enhance overall asthma control, reduce nocturnal awakenings, and improve patients’ quality of life.^5,12,15,44Diabetes and Metabolic DisordersThe β-cell of the pancreas, insulin sensitivity, and glucose tolerance all fluctuate during the day, and it is found that the body’s handling of carbohydrates is better in the morning than in the evening. ⁴⁵ Studies mention that administering oral hypoglycemic medications in the treatment of type 2 diabetes is more effective during periods of higher resistance.⁴⁶ Time-targeted strategies, which aim to synchronize external cues with the molecular clock to improve metabolic outcomes, have positive effects on metabolism in humans, with several studies showing that time-targeted feeding improves body weight loss and glucose tolerance.⁴⁷Neurological DisordersNeurological and neurodegenerative diseases such as epilepsy, Parkinson disease, and Alzheimer disease are strongly associated with circadian disruption.⁴⁸
Epilepsy: studies found that seizures are clearly governed by circadian rhythm; therefore, seizure control is achieved using chronotherapy.⁴⁹ Improving antiepileptic efficacy and reducing their adverse drug reactions were highly associated with the timing of administration of the drugs to the patient’s individual seizure susceptibility rhythms.
Parkinson Disease: Motor symptoms, such as tremors and rigidity, and non-motor symptoms, like sleep disturbances, often exhibit diurnal fluctuations, suggesting potential benefits from timed dopaminergic therapies.⁵⁰Alzheimer DiseaseCircadian rhythm dysfunction may aggravate Alzheimer disease (AD) and contribute to cognitive decline. Cognitive enhancers may offer a therapeutic option.⁵¹
Although there is still interest in symptomatic agents that address sleep and circadian processes, clinical development pipelines indicate that there are currently few late-stage cognitive enhancers that specifically target circadian biology.^52,53Psychiatric DisordersCircadian rhythm disruption is closely associated with bipolar disorder, depression, and mood disorders.²⁴ As a result, chronotherapeutic strategies, like light therapy or timed antidepressant administration, may greatly stabilize mood and enhance sleep patterns in afflicted people.⁵⁴ By leveraging the fact that neurotransmitter synthesis and receptor sensitivity are also influenced by circadian rhythms, this strategy enables more accurate pharmacological interventions that increase therapeutic benefit.³ This thorough comprehension emphasizes how important it is to take circadian biology into account when developing and administering drugs in a variety of clinical settings. The field of pharmaceutics has expanded due to the growing interest in chronopharmacology, and many more sub-disciplines are anticipated to coexist soon.⁵⁵ By releasing therapeutic agents at precise times that correspond to patients’ circadian rhythms and disease chronopharmacology, the development of chronotherapeutics—particularly pulsatile drug delivery systems—represents a substantial advancement in optimizing drug efficacy.⁵⁶ This novel strategy maximizes therapeutic results while reducing adverse effects by ensuring that the drug’s maximum effect occurs during the time of greatest symptomatic manifestation or physiological vulnerability.³⁹ Targeted drug release is made possible by this technique, which is essential for diseases like cardiovascular and inflammatory disorders that show significant diurnal variations in their pathophysiology.Immunology and InfectionsStrong circadian regulation is present in the immune system; different times of day have an impact on infection susceptibility, inflammation, and vaccine responses.⁵⁷ Given the circadian rhythmicity of immune function, the timing of immunomodulatory treatments or antimicrobial agents may have a substantial impact on their effectiveness and minimize adverse drug reactions.² Some studies stated that vaccinations administered in the morning elicit stronger antibody responses than those administered in the afternoon.²⁴ This phenomenon is explained by the fact that antigen-presenting cells and T helper cells are most active in the early hours of the day, which results in a stronger adaptive immune response.⁵⁸ For medications with limited therapeutic indices, where exact temporal control can greatly enhance safety and efficacy profiles, this optimization approach is especially pertinent.³⁹ This exact temporal control has been made possible by the development of chronomodulated drug delivery systems, which include technologies such as Diffucaps, osmotic release oral system (OROS), and 3D printing, which allow for drug release profiles that are customized to particular circadian patterns.⁵⁰Pharmacokinetics and Pharmacodynamics in ChronotherapyUnderstanding how drug timing affects pharmacokinetics (PK) and pharmacodynamics (PD) is essential for chronotherapy.PharmacokineticsLonger exposure may result from a drug’s slower metabolism when taken at night; for instance, theophylline clearance is slower at night.¹² Because hepatic enzymes’ circadian rhythms mediate this diurnal variation in drug metabolism, dosing schedules must be carefully considered in order to maintain therapeutic concentrations and reduce toxicity. Bioavailability and tissue penetration may also be affected by time-dependent changes in drug absorption and distribution influenced by circadian rhythms.⁴ Overall, these pharmacokinetic temporal dynamics highlight the need for customized chronotherapeutic regimens to account for interpatient variation in drug disposition.¹⁴PharmacodynamicsHormones, enzymes, and receptors frequently exhibit their highest activity during particular periods. For example, in accordance with natural cortisol rhythms, glucocorticoid receptors are most responsive in the morning.⁵⁹ Drug efficacy is influenced by this rhythmic sensitivity, which makes chronotherapeutic interventions possible to maximize desired physiological responses and reduce adverse drug reactions.¹² By ensuring that drug administration coincides with the body’s peak responsiveness, this synchronization maximizes therapeutic outcomes while minimizing potential side effects. Therefore, this method requires a deep comprehension of the complex interactions between endogenous circadian oscillators and pharmaceutical agents.⁶⁰Challenges in ChronotherapyChronotherapy faces several challenges despite recent advances and its potential clinical applications.Patient AdherencePatient compliance and adherence are strongly associated with once-daily dosing, while polypharmacy and complicated schedules can make people less compliant.³⁹ Additionally, people who work shifts or have different daily routines may find it difficult to meet the requirement for exact timing.Individual VariabilityCircadian rhythms are influenced by genetics, lifestyle, and chronotype (morning larks vs. night owls), making it challenging to offer general recommendations.⁶¹ This intrinsic variability underscores the need for customized chronotherapeutic approaches tailored to each patient’s unique physiological rhythms rather than universal recommendations.⁸Healthcare System LimitationsClinics and hospitals frequently follow set schedules rather than responding to their patients’ needs.³⁹ The application of chronotherapy may be hampered by this structural rigidity, as it might not align with the optimal times for each patient to receive their medications.⁶²Drug FormulationNot all medications are available in formulations that enable sustained release or adjustable timing.⁹ To overcome this restriction, it is essential to develop chronomodulated drug delivery systems, such as pulsatile-release formulations, that enable precise temporal drug delivery in accordance with circadian rhythms.⁶³ Additionally, a major obstacle to chronotherapy’s broad acceptance and efficient application in patient care is the absence of established procedures for incorporating it into standard clinical practice.⁶⁴Clinical EvidenceAlthough chronotherapy is supported by numerous studies, few large-scale randomized controlled trials are available for many diseases.⁹ Because clinicians value evidence-based practices, this lack of solid clinical data frequently prevents widespread adoption.Digital Health ToolsBy monitoring sleep, heart rate, and circadian markers, smartwatches and biosensors can help customize medication timing to suit personal schedules.ChronopharmacogenomicsTreatment regimens may be customized by understanding how genetic variations in clock genes affect drug metabolism.⁶⁰ Additionally, there is great promise for improving individualized chronotherapeutic approaches in the emerging field of chronopharmacogenomics, which investigates how genetic variations in circadian clock genes affect drug metabolism and response.^65,66 Chronotherapy is positioned as a crucial frontier in precision medicine due to the convergence of biological insights and technological advancements, which go beyond generalized dosing schedules to highly customized therapeutic interventions.^67,68Artificial IntelligenceAI algorithms may analyze patient information to forecast the best time to take medication.⁹ To dynamically optimize drug administration schedules, these models could incorporate a variety of datasets, such as physiological parameters, genetic predispositions, and environmental factors.Drug Delivery SystemsNew formulations that synchronize drug delivery with circadian patterns include chronomodulated-release tablets and programmable pumps.⁵⁰ For conditions ranging from cancer to cardiovascular diseases, where circadian rhythms significantly influence drug response and disease progression, this precision in drug delivery is essential for maximizing treatment efficacy.^39,69

Limitations

The manuscript’s primary academic limitation is that it is a narrative review that synthesizes existing literature rather than presenting new empirical data. Its conclusions are inherently constrained by the nascent state of the chronotherapy field, which, as noted in the work, often lacks the large-scale randomized controlled trials necessary for widespread clinical adoption. Furthermore, the review details significant practical barriers that limit the real-world application of its concepts, including individual variability in circadian rhythms, challenges with patient adherence to complex schedules, the rigidity of health care systems, and the lack of suitable drug formulations.

Conclusion

Overall, chronotherapy has the potential to transform medicine from a static field to one that is dynamic and time-sensitive.¹ By utilizing the body’s natural rhythms, this paradigm shift has the potential to greatly enhance treatment outcomes and bring health care closer to being truly customized and optimized.² By incorporating their individual physiological timing into their treatment plans, this method not only improves therapeutic efficacy and reduces adverse drug reactions but also gives patients more control over their care.^3,4
Chronotherapy is an emerging medical paradigm shift that serves as a utility for health care providers to enhance therapeutic outcomes, reduce toxicity, and optimize medical care. Advances in chronobiology, technology, and pharmacology are opening the door to routine clinical application, despite ongoing challenges, especially in patient adherence, health care logistics, and customized timing. Chronotherapy serves as a reminder that medicine encompasses more than just illnesses and molecules; it also involves balancing with time.

Declarations

Abbreviations

References

1. Fey RM, Billo A, Clister T, et al. Personalization of cancer treatment: Exploring the Role of Chronotherapy in Immune Checkpoint Inhibitor Efficacy. Cancers. 2025;17(5):732. doi:10.3390/cancers17050732
   Article · PubMed · Google Scholar
2. Cederroth CR, Albrecht U, Bass J, et al. Medicine in the fourth dimension. Cell Metabolism. 2019;30(2):238-50. doi:10.1016/j.cmet.2019.06.019
   Article · PubMed · Google Scholar
3. Smolensky MH, Hermida RC, Geng YJ. Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes. Curr Opin Pharmacol. 2021;57:41-8. doi:10.1016/j.coph.2020.10.014
   Article · PubMed · Google Scholar
4. Yu F, Liu Y, Zhang R, Zhu L, Zhang T, Shi Y. Recent advances in circadian- regulated pharmacokinetics and its implications for chronotherapy. Biochem Pharmacol. 2022;203:115185. doi:10.1016/j.bcp.2022.115185
   Article · PubMed · Google Scholar
5. Smith DF, Ruben MD, Francey LJ, Walch OJ, Hogenesch JB. When should you take your medicines? J Biol Rhythms. 2019;34(6):582-3. doi:10.1177/0748730419892099
   Article · PubMed · Google Scholar
6. Aoyama S, Shibata S. Time-of-day-dependent physiological responses to meal and exercise. Front Nutr. 2020;7:18. doi:10.3389/fnut.2020.00018
   Article · PubMed · Google Scholar
7. Paul JR, Rhoads MK, Elam A, Pollock DM, Gamble KL. High-salt diet increases suprachiasmatic neuronal excitability through endothelin receptor type B signaling. Function. 2025;6(2):14. doi:10.1093/function/zqaf014
   Article · PubMed · Google Scholar
8. Nahmias Y, Androulakis IP. Circadian effects of drug responses. Annu Rev Biomed Eng. 2021;23(1):203-24. doi:10.1146/annurev-bioeng-082120-034725
   Article · PubMed · Google Scholar
9. Patil J. Oral drug delivery via chronotherapy approach: need of the day. J Pharmacovigilance. 2017;05(02):1-2. doi:10.4172/2329-6887.1000e167
   Article · PubMed · Google Scholar
10. Butler CT, Rodgers AM, Curtis AM, Donnelly RF. Chrono-tailored drug delivery systems: recent advances and future directions. Drug Deliv and Transl Res. 2024;14(7):1756-75.doi:10.1007/s13346-024-01539-4
    Article · PubMed · Google Scholar
11. Nuszkiewicz J, Rzepka W, Markiel J, Porzych M, Woźniak A, Szewczyk-Golec K. Circadian rhythm disruptions and cardiovascular disease risk: The special role of melatonin. CIMB. 2025;47(8):664. doi:10.3390/cimb47080664
    Article · PubMed · Google Scholar
12. Koyanagi S. Chrono-Pharmaceutical approaches to optimize dosing regimens based on the circadian clock machinery. Biol Pharm Bull. 2021;44(11):1577-84. doi:10.1248/bpb.b21-00476
    Article · PubMed · Google Scholar
13. Vandenberghe A, Lefranc M, Furlan A. An overview of the circadian clock in the frame of chronotherapy: From bench to bedside. Pharmaceutics. 2022;14(7):1424. doi:10.3390/pharmaceutics14071424
    Article · PubMed · Google Scholar
14. Ballesta A, Innominato PF, Dallmann R, Rand DA, Lévi FA. Systems chronotherapeutics. Pharmacol Rev. 2017;69(2):161-99. doi:10.1124/ pr.116.013441
    PubMed · Google Scholar
15. Krakowiak K, Durrington HJ. The role of the body clock in asthma and COPD: Implication for treatment. Pulm Ther. 2018;4(1):29-43.doi:10.1007/s41030-018- 0058-6
    Article · PubMed · Google Scholar
16. Patton AP, Hastings MH. The mammalian circadian time-keeping system. J Huntingtons Dis. 2023;12(2):91-104. doi:10.3233/JHD-230571
    Article · PubMed · Google Scholar
17. Begemann K, Neumann A, Oster H. Regulation and function of extra-SCN circadian oscillators in the brain. Acta Physiologica. 2020;229(1):e13446. doi:10.1111/apha.13446
    Article · PubMed · Google Scholar
18. Bazhanova ED. Desynchronosis: Types, main mechanisms, role in the pathogenesis of epilepsy and other diseases: A literature review. Life. 2022;12(8):1218. doi:10.3390/life12081218
    Article · PubMed · Google Scholar
19. Bicker J, Alves G, Falcão A, Fortuna A. Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics. British J Pharmacology. 2020;177(10):2215-39. doi:10.1111/bph.15017
    Article · PubMed · Google Scholar
20. Chowdhury D, Wang C, Lu AP, Zhu HL. Understanding quantitative circadian regulations are crucial towards advancing chronotherapy. Cells. 2019;8(8):883. doi:10.3390/cells8080883
    Article · PubMed · Google Scholar
21. Oster H, Van Der Horst GTJ, Albrecht U. Daily variation of clock output gene activation in behaviorally arrhythmic mPer / mCry triple mutant mice. Chronobiol Int. 2003;20(4):683-95. doi:10.1081/cbi-120022408
    Article · PubMed · Google Scholar
22. Jarmusch AK, Vrbanac A, Momper JD, et al. Enhanced characterization of drug metabolism and the influence of the intestinal microbiome: A pharmacokinetic, microbiome, and untargeted metabolomics study. Clinical Translational Sci. 2020;13(5):972-84. doi:10.1111/cts.12785
    Article · PubMed · Google Scholar
23. Piedras ALR, Sánchez UB, Hernández EGO, Romero AC. Chronopharmacokinetics: A brief analysis of the influence of circadian rhythm on the absorption, distribution, metabolism, and elimination of drugs. Biomed Pharmacol J. 2024;17(3):2011-7.
    PubMed · Google Scholar
24. Colita CI, Hermann DM, Filfan M, et al. Optimizing chronotherapy in psychiatric care: The impact of circadian rhythms on medication timing and efficacy. Clocks Sleep. 2024;6(4):635-55. doi:10.3390/clockssleep6040043
    Article · PubMed · Google Scholar
25. Sletten TL, Cappuccio FP, Davidson AJ, Van Cauter E, Rajaratnam SMW, Scheer FAJL. Health consequences of circadian disruption. Sleep. 2020;43(1):zsz194. doi:10.1093/sleep/zsz194
    Article · PubMed · Google Scholar
26. Dong D, Yang D, Lin L, Wang S, Wu B. Circadian rhythm in pharmacokinetics and its relevance to chronotherapy. Biochem Pharmacol. 2020;178:114045. doi:10.1016/j.bcp.2020.114045
    Article · PubMed · Google Scholar
27. Erkekoglu P, Baydar T. Chronopharmacodynamics of drugs in toxicological aspects: A short review for clinical pharmacists and pharmacy practitioners. J Res Pharm Pract. 2012;1(2):41. doi:10.4103/2279-042X.108369
    Article · PubMed · Google Scholar
28. Baraldo M. The influence of circadian rhythms on the kinetics of drugs in humans. Expert Opin Drug Metab Toxicol. 2008;4(2):175-92. doi:10.1517/17425255.4.2.175
    Article · PubMed · Google Scholar
29. Ruben MD, Smith DF, FitzGerald GA, Hogenesch JB. Dosing time matters. Science. 2019;365(6453):547-9. doi:10.1126/science.aax7621
    Article · PubMed · Google Scholar
30. Mermet J, Yeung J, Naef F. Systems chronobiology: Global analysis of gene regulation in a 24-Hour periodic world. Cold Spring Harb Perspect Biol. 2017;9(3):a028720. doi:10.1101/cshperspect.a028720
    Article · PubMed · Google Scholar
31. Zeng Y, Guo Z, Wu M, Chen F, Chen L. Circadian rhythm regulates the function of immune cells and participates in the development of tumors. Cell Death Discov. 2024;10(1):199. doi:10.1038/s41420-024-01960-1
    Article · PubMed · Google Scholar
32. Franzago M, Alessandrelli E, Notarangelo S, Stuppia L, Vitacolonna E. Chrono- nutrition: Circadian rhythm and personalized nutrition. IJMS. 2023;24(3):2571. doi:10.3390/ijms24032571
    Article · PubMed · Google Scholar
33. Sardon Puig L, Valera-Alberni M, Cantó C, Pillon NJ. Circadian rhythms and mitochondria: Connecting the dots. Front Genet. 2018;9:452. doi:10.3389/ fgene.2018.00452
    PubMed · Google Scholar
34. Khodasevich D, Tsui S, Keung D, Skene DJ, Revell V, Martinez ME. Characterizing the modern light environment and its influence on circadian rhythms. Proc R Soc B. 2021;288(1955):0721. doi:10.1098/rspb.2021.0721
    Article · PubMed · Google Scholar
35. Festus ID, Spilberg J, Young ME, et al. Pioneering new frontiers in circadian medicine chronotherapies for cardiovascular health. TEM. 2024;35(7):607-23. doi:10.1016/j.tem.2024.02.011
    Article · PubMed · Google Scholar
36. Portaluppi F, Lemmer B. Chronobiology and chronotherapy of ischemic heart disease. Adv Drug Deliv Rev. 2007;59(9-10):952-65. doi:10.1016/j.addr.2006.07.029
    Article · PubMed · Google Scholar
37. Tsimakouridze EV, Alibhai FJ, Martino TA. Therapeutic applications of circadian rhythms for the cardiovascular system. Front Pharmacol. 2015;6:77. doi:10.3389/fphar.2015.00077
    Article · PubMed · Google Scholar
38. Soares AC, Fonseca DA. Cardiovascular diseases: a therapeutic perspective around the clock. Drug Discov. Today. 2020;25(6):1086-98. doi:10.1016/j.drudis.2020.04.006
    Article · PubMed · Google Scholar
39. Vijayan AS, R S, G BJ, Samuel J. A Review on chronotherapy, a time programmed drug delivery. IJPSRR. 2020;64(1):173-8. doi:10.47583/ijpsrr.2020.v64i01.031
    Article · PubMed · Google Scholar
40. Amiama-Roig A, Verdugo-Sivianes EM, Carnero A, Blanco JR. Chronotherapy: Circadian rhythms and their influence in cancer therapy. Cancers. 2022;14(20):5071. doi:10.3390/cancers14205071
    Article · PubMed · Google Scholar
41. Tang Q, Xie M, Yu S, et al. Periodic Oxaliplatin administration in synergy with PER2-mediated PCNA transcription repression promotes chronochemotherapeutic efficacy of OSCC. Adv Sci. 2019;6(21):1900667. doi:10.1002/advs.201900667
    Article · PubMed · Google Scholar
42. Giacchetti S, Bjarnason G, Garufi C, et al. Phase III trial comparing 4-Day chronomodulated therapy versus 2-Day conventional delivery of Fluorouracil, Leucovorin, and Oxaliplatin as first-line chemotherapy of metastatic colorectal cancer. JCO. 2006;24(22):3562-9. doi:10.1200/JCO.2006.06.1440
    Article · PubMed · Google Scholar
43. Kilgallen AB, Štibler U, Printezi MI, et al. Comparing conventional chemotherapy to chronomodulated chemotherapy for cancer treatment: Protocol for a systematic review. JMIR Res Protoc. 2020;9(10):e18023.doi:10.2196/18023
    Article · PubMed · Google Scholar
44. Paudel KR, Jha SK, Allam VSRR, et al. Recent advances in chronotherapy targeting respiratory diseases. Pharmaceutics. 2021;13(12):2008. doi:10.3390/pharmaceutics13122008
    Article · PubMed · Google Scholar
45. Matejko B, Kukułka A, Kieć-Wilk B, Stąpór A, Klupa T, Malecki MT. Basal Insulin dose in adults with type 1 Diabetes Mellitus on Insulin pumps in real- life clinical practice: A single-center experience. Adv Med. 2018;2018:1-5. doi:10.1155/2018/1473160
    Article · PubMed · Google Scholar
46. Fujimoto R, Ohta Y, Masuda K, et al. Metabolic state switches between morning and evening in association with circadian clock in people without diabetes. J of Diabetes Invest. 2022;13(9):1496-505. doi:10.1111/jdi.13810
    Article · PubMed · Google Scholar
47. Dollet L, Pendergrast LA, Zierath JR. The role of the molecular circadian clock in human energy homeostasis. Curr Opin Lipidol. 2021;32(1):16-23. doi:10.1097/ MOL.0000000000000722
    PubMed · Google Scholar
48. Fuad SA, Ginting RP, Lee MW. Chrononutrition: Potential, challenges, and application in managing obesity. IJMS. 2025;26(11):5116. doi:10.3390/ ijms26115116
    PubMed · Google Scholar
49. Parravano M, Eandi C, Figus M, et al. Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts. Eur J Ophthalmol. 2022;32(5):2489-93. doi:10.1177/11206721221106149
    Article · PubMed · Google Scholar
50. Mallamma T, Prakash Goudanavar, Nagaraja Sreeharsha, Santosh Fattepur. Chrono modulated therapy-A review. IJRPS. 2020;11(SPL4):2884-90. doi:10.26452/ijrps.v11iSPL4.4575
    Article · PubMed · Google Scholar
51. Ahmad F, Sachdeva P, Sarkar J, Izhaar R. Circadian dysfunction and Alzheimer’s disease - An updated review. Aging Med (Milton). 2023;6(1):71-81. doi:10.1002/agm2.12221
    Article · PubMed · Google Scholar
52. Cummings J. New approaches to symptomatic treatments for Alzheimer’s disease. Mol Neurodegeneration. 2021;16(1):2. doi:10.1186/s13024-021-00424- 9
    Article · PubMed · Google Scholar
53. Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F. Alzheimer’s disease drug development pipeline. Clin Interv. 2024;10(2):e12465. doi:10.1002/ trc2.12465
    PubMed · Google Scholar
54. Fishbein AB, Knutson KL, Zee PC. Circadian disruption and human health. J Clin Invest. 2021;131(19):e148286. doi:10.1172/JCI148286
    Article · PubMed · Google Scholar
55. Rajput A, Pingale P, Telange D, Musale S, Chalikwar S. A current era in pulsatile drug delivery system: Drug journey based on chronobiology. Heliyon. 2024;10(10):e29064. doi:10.1016/j.heliyon.2024.e29064
    Article · PubMed · Google Scholar
56. Anusha V, Umashankar MS, Kumar YG. Pulsatile drug delivery system — an innovative method to treat chronotherapeutic diseases by synchronizing drug delivery with circadian rhythm. J Appl Pharm Sci. 2023:13(12):066-078. doi:10.7324/JAPS.2023.125025
    Article · PubMed · Google Scholar
57. Ding J, Chen P, Qi C. Circadian rhythm regulation in the immune system. Immunology. 2024;171(4):525-33. doi:10.1111/imm.13747
    Article · PubMed · Google Scholar
58. Ayyar VS, Sukumaran S. Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions. J Pharmacokinet Pharmacodyn. 2021;48(3):321-38. doi:10.1007/s10928-021-09751-2
    Article · PubMed · Google Scholar
59. Scherholz ML, Schlesinger N, Androulakis IP. Chronopharmacology of glucocorticoids. Adv Drug Deliv Rev. 2019;151-152:245-61. doi:10.1016/j.addr.2019.02.004
    Article · PubMed · Google Scholar
60. Ohdo S, Koyanagi S, Matsunaga N. Chronopharmacological strategies focused on chrono-drug discovery. Pharmacology & Therapeutics. 2019;202:72-90. doi:10.1016/j.pharmthera.2019.05.018
    Article · PubMed · Google Scholar
61. Mentzelou M, Papadopoulou SK, Papandreou D, et al. Evaluating the relationship between circadian rhythms and sleep, metabolic and cardiovascular disorders: Current clinical evidence in human studies. Metabolites. 2023;13(3):370. doi:10.3390/metabo13030370
    Article · PubMed · Google Scholar
62. Selfridge JM, Gotoh T, Schiffhauer S, et al. Chronotherapy: Intuitive, sound, founded…but not broadly applied. Drugs. 2016;76(16):1507-21. doi:10.1007/s40265-016-0646-4
    Article · PubMed · Google Scholar
63. Sajan J, Cinu T, Chacko A, Litty J, Jaseeda T. Chronotherapeutics and chronotherapeutic drug delivery systems. Trop J Pharm Res. 2009;8(5): 467-75. doi:10.4314/tjpr.v8i5.48091
    Article · PubMed · Google Scholar
64. Walton JC, Walker WH, Bumgarner JR, et al. Circadian variation in efficacy of medications. Clin Pharma and Therapeutics. 2021;109(6):1457-88. doi:10.1002/cpt.2073
    Article · PubMed · Google Scholar
65. Achari KV. Chronobiology and chrono pharmacology with reference to consequences and management of shift work. JMPAS. 2022;11(1):4087-92.
    PubMed · Google Scholar
66. Youan BBC. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? J Control Release. 2004;98(3):337-53. doi:10.1016/j.jconrel.2004.05.015
    Article · PubMed · Google Scholar
67. Kaşkal M, Sevim M, Ülker G, Keleş C, Bebitoğlu BT. The clinical impact of chronopharmacology on current medicine. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(6):6179-91. doi:10.1007/s00210-025-03788-7
    Article · PubMed · Google Scholar
68. Dobrek L. Chronopharmacology in therapeutic drug monitoring—dependencies between the rhythmics of pharmacokinetic processes and drug concentration in blood. Pharmaceutics. 2021;13(11):1915. doi:10.3390/pharmaceutics13111915
    Article · PubMed · Google Scholar
69. Mandal AS, Biswas N, Karim KM, et al. Drug delivery system based on chronobiology—A review. J Control Release. 2010;147(3):314-25. doi:10.1016/j.jconrel.2010.07.122
    Article · PubMed · Google Scholar

Additional Information

Publisher’s Note
Bayrakol MP remains neutral with regard to jurisdictional and institutional claims.

Rights and Permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/

View full license details →